Previous 10 | Next 10 |
Shares of Elanco Animal Health (NYSE:ELAN) are down 5% in Monday morning trading after the company issued updated 2022 guidance including revenue below expectations. 2022 revenue guidance of $4.7B-~$4.76B (prior ~$4.75B-$4.8B) is below consensus of $4.77B. The company said that the ...
The following slide deck was published by Elanco Animal Health Incorporated in conjunction with their 2022 Q1 earnings call. For further details see: Elanco Animal Health Incorporated 2022 Q1 - Results - Earnings Call Presentation
Elanco press release (NYSE:ELAN): Q1 Non-GAAP EPS of $0.36 beats by $0.01. Revenue of $1.23B (-0.8% Y/Y) beats by $10M. Updating full year 2022 revenue guidance to be $4,700 to $4,755 million vs. consensus of $4.77B, due to the negative impact of foreign exchange rates; constant currency reve...
First Quarter 2022 Financial Results Revenue of $1,225 million Reported Net Income of $48 million, Adjusted Net Income of $177 million Adjusted EBITDA of $339 million or 27.7% of Revenue Reported EPS of $0.10, Adjusted EPS of $0.36 ...
Elanco Animal Health (NYSE:ELAN) has obtained the exclusive U.S. licensing rights to Bovaer, methane-reducing feed additive approved in Europe, Brazil, Chile and Australia for beef and dairy cattle. The transaction announced on Monday follows a strategic alliance with Royal DSM, under which t...
The strategic alliance connects two sustainability leaders, Elanco, a leading animal health company, and Royal DSM, a health, nutrition and biosciences company, to accelerate tangible sustainable solutions in the U.S., supporting the Global Methane Pledge goal of cutting emissions 30%...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
Elanco Animal Health is coming off a record 2021 highlighted by strong earnings. The stock has been under pressure amid macro concerns including an ongoing Bird Flu outbreak with an uncertain impact on the company's poultry business. We like the stock following on the selloff with...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
Elanco Animal Health Incorporated (NYSE: ELAN) will announce its first quarter 2022 financial results on Monday, May 9, 2022. Elanco will also conduct a conference call on that day with the investment community and media to further detail the company’s performance. The confer...
News, Short Squeeze, Breakout and More Instantly...
Elanco Animal Health Incorporated Company Name:
ELAN Stock Symbol:
NYSE Market:
Elanco Animal Health Incorporated Website:
NORTHAMPTON, MA / ACCESSWIRE / July 23, 2024 / Feeding dairy cows Bovaer® (3-NOP), Elanco's newest feed ingredient , provides a scalable and credible way for dairy farmers to benefit from being good stewards of the environment by being financially rewarded for implementing on-farm sustaina...
Elanco Confirms Date and Conference Call for Second Quarter 2024 Financial Results Announcement PR Newswire GREENFIELD, Ind. , July 18, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will announce its second quarter 2024 financial results on ...
SAN FRANCISCO, CA / ACCESSWIRE / July 17, 2024 / Hagens Berman urges Elanco Animal Health Incorporated (NYSE:ELAN) investors who suffered substantial losses to submit your losses now . Visit: www.hbsslaw.com/investor-fraud/elan Contact the Firm Now: ELAN@hbsslaw.com 844-916-0895 ...